IL150384A0 - Radiolabelled somatostatin analogs backbone cyclized through metal complexation - Google Patents

Radiolabelled somatostatin analogs backbone cyclized through metal complexation

Info

Publication number
IL150384A0
IL150384A0 IL15038402A IL15038402A IL150384A0 IL 150384 A0 IL150384 A0 IL 150384A0 IL 15038402 A IL15038402 A IL 15038402A IL 15038402 A IL15038402 A IL 15038402A IL 150384 A0 IL150384 A0 IL 150384A0
Authority
IL
Israel
Prior art keywords
somatostatin analogs
metal complexation
backbone cyclized
radiolabelled somatostatin
radiolabelled
Prior art date
Application number
IL15038402A
Other languages
English (en)
Original Assignee
Peptor Ltd
Yissum Res Dev Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Peptor Ltd, Yissum Res Dev Co filed Critical Peptor Ltd
Priority to IL15038402A priority Critical patent/IL150384A0/xx
Publication of IL150384A0 publication Critical patent/IL150384A0/xx
Priority to JP2004515410A priority patent/JP2005538966A/ja
Priority to PCT/IL2003/000531 priority patent/WO2004000204A2/en
Priority to AU2003241142A priority patent/AU2003241142A1/en
Priority to EP03730462A priority patent/EP1539216A2/de
Priority to US11/021,885 priority patent/US20050226813A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/083—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins the peptide being octreotide or a somatostatin-receptor-binding peptide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/655—Somatostatins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Cardiology (AREA)
  • Molecular Biology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Vascular Medicine (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
IL15038402A 2002-06-24 2002-06-24 Radiolabelled somatostatin analogs backbone cyclized through metal complexation IL150384A0 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
IL15038402A IL150384A0 (en) 2002-06-24 2002-06-24 Radiolabelled somatostatin analogs backbone cyclized through metal complexation
JP2004515410A JP2005538966A (ja) 2002-06-24 2003-06-24 金属錯体形成により環化した標識ソマトスタチン同族体骨格
PCT/IL2003/000531 WO2004000204A2 (en) 2002-06-24 2003-06-24 Labelled somatostatin analogs backbone cyclized through metal complexation
AU2003241142A AU2003241142A1 (en) 2002-06-24 2003-06-24 Labelled somatostatin analogs backbone cyclized through metal complexation
EP03730462A EP1539216A2 (de) 2002-06-24 2003-06-24 Durch metallkomplexbildung zyklisiertes markiertes somatostatin-analoga-gerüst
US11/021,885 US20050226813A1 (en) 2002-06-24 2004-12-23 Labelled somatostatin analogs backbone cyclized through metal complexation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL15038402A IL150384A0 (en) 2002-06-24 2002-06-24 Radiolabelled somatostatin analogs backbone cyclized through metal complexation

Publications (1)

Publication Number Publication Date
IL150384A0 true IL150384A0 (en) 2002-12-01

Family

ID=28053395

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15038402A IL150384A0 (en) 2002-06-24 2002-06-24 Radiolabelled somatostatin analogs backbone cyclized through metal complexation

Country Status (6)

Country Link
US (1) US20050226813A1 (de)
EP (1) EP1539216A2 (de)
JP (1) JP2005538966A (de)
AU (1) AU2003241142A1 (de)
IL (1) IL150384A0 (de)
WO (1) WO2004000204A2 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005123761A1 (en) * 2004-06-21 2005-12-29 Yissum Research Development Company Of The Hebrew University Of Jerusalem GnRH ANALOGS BACKBONE CYCLIZED THROUGH METAL COMPLEXATION
CA2727803C (en) 2008-05-13 2013-03-12 University Of Kansas Metal abstraction peptide (map) tag and associated methods
WO2013181461A2 (en) 2012-06-01 2013-12-05 University Of Kansas Metal abstraction peptide with superoxide dismutase activity

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4980147A (en) * 1984-06-25 1990-12-25 University Of Utah Research Foundation Radiolabeled technetium chelates for use in renal function determinations
US4883862A (en) * 1988-04-13 1989-11-28 Albert Einstein College Of Medicine - Of Yeshiva University Mercaptosuccinyl glycyl-glycyl-glycine a complex thereof with Tc-99m, and methods of making the same
JP2798789B2 (ja) * 1990-06-05 1998-09-17 キヤノン株式会社 画像受信装置
US5382654A (en) * 1992-02-05 1995-01-17 Mallinckrodt Medical, Inc. Radiolabelled peptide compounds
US5225180A (en) * 1991-09-10 1993-07-06 Diatech, Inc. Technetium-99m labeled somatostatin-derived peptides for imaging
IL99628A (en) * 1991-10-02 2004-07-25 Yissum Res Dev Co Processes for the preparation of cyclic peptides, and pharmaceutical compositions containing them
US5620675A (en) * 1992-06-23 1997-04-15 Diatech, Inc. Radioactive peptides
US5932189A (en) * 1994-07-29 1999-08-03 Diatech, Inc. Cyclic peptide somatostatin analogs
IL109943A (en) * 1994-06-08 2006-08-01 Develogen Israel Ltd Conformationally constrained backbone cyclized peptide analogs
US5770687A (en) * 1995-06-07 1998-06-23 Peptor Limited Comformationally constrained backbone cyclized somatostatin analogs
US6051554A (en) * 1995-06-07 2000-04-18 Peptor Limited Conformationally constrained backbone cyclized somatostatin analogs
US6331285B1 (en) * 1996-06-05 2001-12-18 Palatin Technologies, Inc. Structurally determined cyclic metallo-constructs and applications
US6355613B1 (en) * 1996-07-31 2002-03-12 Peptor Limited Conformationally constrained backbone cyclized somatostatin analogs
IL141276A0 (en) * 2001-02-05 2002-03-10 Peptor Ltd Backbone cyclized radiolabelled somatostatin analogs

Also Published As

Publication number Publication date
EP1539216A2 (de) 2005-06-15
WO2004000204A3 (en) 2005-03-24
WO2004000204A8 (en) 2004-03-18
AU2003241142A1 (en) 2004-01-06
JP2005538966A (ja) 2005-12-22
US20050226813A1 (en) 2005-10-13
AU2003241142A8 (en) 2004-01-06
WO2004000204A2 (en) 2003-12-31

Similar Documents

Publication Publication Date Title
AU2002247447A8 (en) Improved ling carrier
EP1538229A4 (de) Hochfeste kupferlegierung
IL141276A0 (en) Backbone cyclized radiolabelled somatostatin analogs
AU2003262802A8 (en) Riser connector
IL166170A0 (en) Ghrelin analogs
AU2003296660A8 (en) Copolyamides
PL368941A1 (en) Somatostatin agonists
EP1553213A4 (de) Abscheidung einer legierung auf kupfer-zinn-sauerstoff-basis
PL362838A1 (en) Somatostatin antagonists
GB0216154D0 (en) Metal chelates
AU2003241142A8 (en) Labelled somatostatin analogs backbone cyclized through metal complexation
EP1425258A4 (de) Hydroxyeicoseinsäureanaloga
PL377054A1 (pl) Poliamidy
GB0212327D0 (en) Comparator
GB0201465D0 (en) Pre-mri metal detector
AU155233S (en) Covered bicycle
GB0100285D0 (en) Gold alloy for firing on porcelain
GB2386336B (en) Wire retainer casing
AU2003239364A8 (en) Sequence detection
TW579873U (en) Twisting-driven bike
GB2376641B (en) Muscle builder
AU149643S (en) Metal detector
SI1504131T1 (sl) Alfa-beta Ti-Al-V-Mo-Fe zlitina
GB0214945D0 (en) Sequences
GB0215980D0 (en) Sequences